Numerous studies have demonstrated that the spike glycoprotein of coronaviruses bears major determinants of pathogenesis. To elucidate the antigenic structure of the protein, a panel of monoclonal antibodies was studied by competitive ELISA, and their reactivities were assayed against fragments of the murine coronavirus murine hepatitis virus strain A59 S gene expressed in prokaryotic vectors. An immunodominant linear domain was localized within the predicted stalk, S2, of the peplomer. It is recognized by several neutralizing antibodies. Other domains were also identified near the proteolytic cleavage site, in the predicted globular head, Si, and in another part of the stalk. Furthermore, competition results suggest that the immunodominant functional domain forms part of a complex three-dimensional structure. Surprisingly, some antibodies which have no antiviral biological activities were shown to bind the immunodominant neutralization domain.
Members of the Coronaviridae are enveloped positivestranded RNA viruses responsible for a variety of acute and chronic diseases of the respiratory, gastrointestinal, and neurological systems (29, 37, 44) . The latter characteristic has stimulated studies on the murine hepatitis virus (MHV) as an animal model of virus-induced diseases of the central nervous system, using the neurotropic JHM, 4, and A59 strains (40) .
Three to four major structural proteins were identified on MHV virions (29) : the nucleoprotein N (50 to 60 kDa), the membrane glycoprotein M (23 to 26 kDa), the hemagglutininesterase glycoprotein HE (65 kDa), identified only on the JHM and DVIM strains, and the spike glycoprotein S (180 to 200 kDa) (4) . The S glycoprotein constitutes the distinctive surface projections or peplomers of the virions, each one consisting of two or three S protein molecules (3, 12) . This protein is also responsible for the initiation and propagation of infection, by interacting with a cellular receptor (47) and inducing cell-to-cell fusion (6, 41) . Proteolytic cleavage of S (33) yields the S1 amino-terminal subunit, which forms the globular head of the peplomer, and the S2 carboxy-terminal moiety, which forms the stalk region. The latter half of the S glycoprotein contains two hydrophobic heptad repeat patterns indicative of two a helices, which predicts an elongated coiled-coil structure (11) . Numerous studies have illustrated, directly or indirectly, the importance of S in coronaviral pathogenicity. In H6A, 2E10.3 (N+)
V: D12 (N-) between II and III: 5B93.9 (N+/-) 6 FIG. 1. Localization of linear epitopes on the S primary structure. The upper bar symbolizes the MHV-A59 S gene, and the horizontal lines represent the fragment library expressed in the pEX vector as described in Materials and Methods. The vertical arrow indicates the S cleavage site to yield the N-terminal S1 and C-terminal S2 moieties, and the opposing horizontal arrows represent the positions of primers used to amplify the immunodominant domain. Reactivities of MAbs could be assigned to the five regions indicated. The corresponding sizes of the protein fragments are as follows: I, 202 amino acids (nucleotides 517 to 1124); II, 132 amino acids (nucleotides 1906 to 2300); III, 50 amino acids (nucleotides 2512 to 2663); IV, 18 amino acids (nucleotides 2663 to 2716); and V, 154 amino acids (nucleotides 3194 to 3656). One weakly neutralizing MAb was mapped to a region between domains II and III (70 amino acids). Epitope A, which was chemically synthesized as the 13-residue peptide A, is indicated; it is localized within domain III.
whereas a MAb specific for residues 395 to 406 in Si had neutralization activity only (26) . Furthermore, Talbot et al. (36) localized an important neutralization site in S2 and showed that a synthetic decapeptide homologous to this domain could immunize against coronavirus-induced encephalitis. Finally, Luytjes et al. (23) , using a prokaryotic pEX vector expression library of the MHV-A59 S glycoprotein, have localized on the S2 moiety the epitope recognized by the in vitro MHV-JHM-neutralizing, fusion-inhibiting, and in vivo protective MAb 5B19.2. A synthetic peptide encompassing this epitope in a proper configuration was shown to induce an immune response that could protect mice against MHV-A59 infection, despite the absence of neutralizing antibodies (20) .
The purpose of this study was to characterize some of the structural and functional domains of the S glycoprotein of murine coronaviruses. We have used the pEX expression library described above to identify the binding sites of a large panel of MAbs representing the combined collections of several laboratories. Our results show that the epitope recognized by MAb 5B19.2 is located within an immunodominant neutralization domain, which is itself part of a more complex conformational functional domain.
MATERIALS AND METHODS
Viruses, cells, and MAbs. MHV-A59 and MHV-JHM were obtained from the American Type Culture Collection (Rockville, Md.), plaque purified twice, and cultured on DBT cells as described previously (8) . MAbs against the S glycoprotein of MHV-JHM and MHV-A59 were raised and characterized as previously described (6, 9, 13, 16, 39, 43) . These MAbs were used mostly as ascites fluids in this study.
MHV antisera. C57BL/6 and AKR mice (Charles River, St-Constant, Quebec, Canada) as well as SJL mice (Jackson Laboratory, Bar Harbor, Maine) were immunized intraperitoneally once with 100 ,ug of purified MHV-A59 emulsified in complete Freund's adjuvant (CFA) and boosted twice at biweekly intervals with the same amount of purified virus in incomplete Freund's adjuvant (IFA). Lewis rats were immunized intradermally with 150 ,ug of purified MHV-A59 emulsified in CFA and boosted 2 weeks later with the same amount of virus in IFA. New Zealand rabbits were immunized subcutaneously once with 400 ,ug of purified MHV-A59 emulsified in CFA and boosted twice at biweekly intervals with the same amount of virus in IFA.
Synthetic peptide. A synthetic peptide encompassing epitope A (23) to which two residues were added on either side, designated peptide A (NH2-S-P-L-L-G-C-I-G-S-T-C-A-E-COOH, amino acids 846 to 858 or nucleotides 2536 to 2574, inclusively), was synthesized chemically (BioChem Pharma Inc., Montreal, Quebec, Canada) as described previously (36) . pEX expression library. A library of fusion proteins containing fragments of the S glycoprotein was constructed as described elsewhere (23) . Briefly, restriction fragments were generated from digestion of the cloned S gene of MHV-A59 and subcloned into an appropriate pEX vector for conservation of a proper reading frame. These fragments were expressed as fusion proteins with 0-galactosidase in Eschenchia coli. Figure 1 (27) . This reaction product was used to transform E. coli HB101 competent cells (17) . Recombinant plasmids with inserts of the appropriate size and orientation were selected and used to transform E. coli BL21(DE3)pLysS competent cells. These cells carry a chromosomal copy of the T7 RNA polymerase gene that is under the control of an isopropylthiogalactopyranoside (IPTG)-inducible promoter (31) . For expression, recombinant bacterial strains were grown at 37°C until the optical density at 600 nm reached 0.6 to 1, after which 1.0 mM IPTG was added to induce synthesis of T7 RNA polymerase. Cells were harvested 2 h after induction and centrifuged at 5,000 x g for 1 min. The cell pellet was resuspended in 50 mM Tris-HCl buffer (pH 8.0), freeze-thawed once, lysed by incubation with 0.2% (vol/vol) Triton X-100 for 40 min on ice, and treated for 30 min at 37°C with 20 ,ug of DNase per ml and 30 mM MgCl2. Lysates were centrifuged at 10,000 x g for 5 ELISAs. The reactivities of MAbs against peptide A were evaluated by enzyme-linked immunosorbent assay (ELISA). The peptide was adsorbed onto wells of a 96-well microplate for 16 h at room temperature at a concentration of 10 ,ug/ml in carbonate buffer (pH 9.6). ELISA was performed as described earlier (39) , with the modification that 0.1% (vol/ vol) Tween 20 was used as the blocking and washing buffer. Epitopes recognized by MAbs were topographically mapped on MHV-JHM S glycoprotein by competitive ELISA, using various amounts of unlabeled and labeled MAbs, as described previously (39) except that biotinylated antibodies (22) and streptavidin-peroxidase (Sigma, St. Louis, Mo.) were used.
RESULTS
Properties of available MAbs. MAbs against the S glycoprotein of MHV-JHM and MHV-A59 were previously characterized for their biological properties and subunit or antigenic site reactivities, as summarized in Table 1 . Biological properties of MAbs included in vitro neutralization of virus infectivity monitored by plaque assays and/or cytopathic effect, inhibition of virus-induced fusion of cells into multinucleated syncytia, and passive in vivo protection after transfer into mice before challenge with a normally lethal viral dose. MAbs from Wege and collaborators (43) were mapped by competitive immunoassays to six antigenic sites, designated A to F. MAbs to either MHV-JHM or MHV-A59 produced by Fleming and collaborators (13, 16) were shown to be specific to the immunizing strain only in the case of J.7.18, J.2.2, and J.7.2. The latter two MAbs were also shown to recognize two topographically distinct antigenic sites by competition ELISA (14) . MAbs from Buchmeier and collaborators (6, 39) recognized separate antigenic sites A to E in competitive immunoassays, and only site B-specific MAb 5A13.5 was specific to the immunizing MHV strain (35) . MAbs from Talbot and collaborators and Anderson and colleagues have been used in unpublished studies, except for 7-1OA and 4-11G (9) . Finally, binding of some MAbs raised against MHV-JHM to chromatographically separated S1 and S2 subunits of MHV-A59 allowed mapping of binding site(s) on either subunit (46) . Some MAbs raised against MHV-A59 (7-1OA.13, 4-11G.6, 1-9F.18, and 3-8B.11, the latter being another clone of 3-8B.3) were also mapped in this way (19) .
Binding of MAbs to pEX library fragments. MAbs that could recognize the denatured S glycoprotein in immunoblotting (results not shown) and thus likely to recognize continuous epitopes, as well as some MAbs that are dependent on the three-dimensional structure of the protein for recognition of discontinuous epitopes, were characterized for their reactivities against the S fragments in immunoblotting. The binding sites of a total of 13 MAbs could be mapped with this technique. As shown in Fig. 1 , five domains could be identified on the primary structure of S to which continuous epitope-dependent MAbs bound. One MAb, designated J.2.2, was previously presumed to recognize a discontinuous epitope, although it appears that at least a portion of the epitope could be mapped with the present procedure. A representative result is shown in Fig. 2A (1-9F.18) recognized an epitope within 202 residues of S1 (domain I), encoded by nucleotides 517 to 1124. Other epitopes were also found around the proteolytic cleavage site of S (domain II, nucleotides 1906 to 2300; 132 residues) and in another part of S2 (domain V, nucleotides 3223 to 3656; 154 residues). The reactivity of MAb J.2.2 with the pEX library fragments was ambiguous since it reacted reproducibly with nonoverlapping fragments 14 and 3, although reaction with the latter was faint (Fig. 2B) . This observation could be explained by the reactivity of the MAb with distant amino acids which form part of a discontinuous antigenic determinant or by a possible contamination of the ascites fluid. However, the latter possibility is unlikely since this ascites fluid showed no reaction against other viral proteins than S in Western immunoblotting (results not shown). Interestingly, MAb 5B93.9, which is weakly neutralizing (Table 1) and of the immunoglobulin A isotype (6), reacted with fragments 3, 4, 9, and 11 (results not shown), which suggests that binding is in S2, between domains II and III.
Antigenicity and immunogenicity of the immunodominant domain. To further characterize the antigenic domain (designated III-IV), its nucleotide sequence was amplified, cloned in the pET 3xa vector, and expressed in bacteria. This S2 fragment also included the upstream binding site for MAb 5B93.9 (Fig. 1) . As shown in Fig. 3 , we first confirmed that only the MAbs previously mapped to this region effectively recognized this newly expressed domain (49.7 kDa). Two antisera raised against synthetic peptides located within this domain (10) also reacted with the fusion protein. MAbs H6A and 2E10.3 showed a reaction with another protein of the bacterial extract of approximately 40 kDa, the nature of which remains undetermined, since it seems unlikely that these antibodies cross-react with the carrier protein, which has a molecular mass of 27.7 kDa. We also verified that the humoral immune response against this domain is not restricted to BALB/c mice, which were used to produce all the MAbs, but rather is part of a normal immune response against MHV in hosts with different genetic backgrounds. As shown in Fig. 4 Lanes: 1 to 3, reactivities of C57BL/6, SJL, and AKR mouse antisera, respectively; 4 and 5, reactivities of preimmune C57BL/6 and AKR sera, respectively; 6 and 7, reactivities of rabbit antisera and preimmune sera, respectively; 8 and 9, reactivities of rat antisera and preimmune sera, respectively; 10, reactivity of a positive control (MAb E17). The migration of molecular mass standards (in kilodaltons) is represented on the right. mapped to the immunodominant domain were assayed by ELISA against a 13-residue synthetic peptide encompassing epitope A, previously identified as the binding site for MAb SB19.2 (23) . MAbs mapped to the 50-residue domain III (5B19.2, SB170.3, E17, J.2.2, and SB207.5) were shown to bind to the peptide, unlike MAbs H6A and 2E10.3 (Fig. 5) (10) .
Competitive ELISA. Topographical relationships between antibodies specific for MHV-JHM were evaluated by a competitive ELISA, using MAbs that could be successfully biotinylated (for unknown reasons, usable reagents could not be produced with some MAbs). Competition between serial dilutions of unlabeled antibody and several fixed amounts of labeled MAb were performed. Results are summarized in Table 2 and represent the highest significant competition levels that could be obtained after several assays.
Analysis of binding and competition data. An overall analysis of the results of this study suggests a complex structure of the S peplomer. Indeed, competition between antibodies that were localized on very distant portions of the S primary sequence was observed, as schematized in Fig. 6 for some important MAbs. It appears that continuous epitopes localized in S2 interact with discontinuous epitopes that have previously been indirectly localized in Si: viral mutants resistant to neutralization by MAb 5A13.5, 4B11.6, or J.7.2 showed modifications in S1 (25, 42) , and MAb Al could compete with an Si-specific MAb for binding to the S glycoprotein (32) . eral neutralizing MAbs that are presumed to recognize continuous epitopes. According to the model proposed by de Groot et al. (11) , this immunodominant domain would be located in the stalk of the peplomer. This domain, expressed as a fusion protein with the phage T7 capsid protein in the pET 3x expression system, was also recognized by hyperimmune sera raised against MHV-A59 in other mouse strains, in rats, and in rabbits. However, immunization of mice with the fusion protein induced a nonprotective virusspecific immune response, which could possibly be explained by an inappropriate conformation of the expressed protein fragment. It is noteworthy that immunization with fragment 14 of the pEX library could induce a protective immune response in mice, whereas fragment 4 could not, although both fragments include epitope A and the immunodominant domain (29a) . This finding suggests that other residues on the carboxy-terminal side of domains III and IV may, in certain circumstances, contribute to the induction of a protective immunity. However, a synthetic peptide encompassing epitope A did induce a protective immune response when coupled to a T epitope from influenza virus (20) or to keyhole limpet hemocyanin (10) . Thus, an alternative explanation for the lack of peptide-induced protection may have to do with the importance of a specific conformation of the injected molecule for the induction of a protective immune response.
Surprisingly, MAb J.2.2, which was previously shown to be specific for MHV-JHM in a radioimmunoassay (13) , reacted in our hands with the MHV-A59 S glycoprotein in Western immunoblotting (results not shown) and MHV-A59 S fragments from the pEX library (Fig. 2) . The use of different variants of MHV-A59, a virus which is known to have a high mutation frequency (1, 15) This study provides some information on the tertiary structure of the S glycoprotein or arrangement of the peplomer. From the pEX expression library and the competition experiments, a complex relationship could be proposed between MAbs that were mapped on the S primary structure and discontinuous epitope-dependent MAbs (Fig. 6) 
